DocSym
β
Searchsearch
Search
(M31.6) Other giant cell arteritis
More details coming soon
861 581 in individuals diagnosis other giant cell arteritis confirmed
31 991 deaths with diagnosis other giant cell arteritis
4% mortality rate associated with the disease other giant cell arteritis
Diagnosis other giant cell arteritis is diagnosed Women are 11.89% more likely than Men
379 577
Men receive the diagnosis other giant cell arteritis
17 557 (4.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
482 004
Women receive the diagnosis other giant cell arteritis
14 434 (3.0 %)Died from this diagnosis.
Risk Group for the Disease other giant cell arteritis - Men and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features other giant cell arteritis
Absence or low individual and public risk
Other giant cell arteritis - what does this mean
Other giant cell arteritis is a type of vasculitis that is caused by an overactive immune system. the immune system mistakenly attacks the cells that line the walls of the arteries, causing inflammation and narrowing of the arteries. this can lead to reduced blood flow and damage to the organs and tissues that rely on the affected arteries.
What happens during the disease - other giant cell arteritis
Other giant cell arteritis is a rare inflammatory disorder that affects the large and medium-sized arteries of the body, leading to narrowing of the affected vessels. it is thought to be caused by an overactive immune response to a viral or bacterial infection, which leads to the release of inflammatory cytokines and the formation of giant cells in the arterial wall. this causes the vessel to become inflamed, leading to decreased blood flow and tissue damage.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
- Imaging tests, such as an ultrasound or MRI
- Biopsy of the affected artery
- Treatment with corticosteroids
- Eye exams to check for vision changes
- Treatment with immunosuppressant drugs
Treatment and Medical Assistance
Main goal of the treatment: To reduce inflammation in the arteries and prevent further damage.
- Prescribe corticosteroid medications to reduce inflammation
- Prescribe immunosuppressant medications to reduce the activity of the immune system
- Prescribe antimalarial medications to reduce inflammation
- Prescribe biologic medications to target specific parts of the immune system
- Provide lifestyle advice to reduce stress and improve overall health
- Provide physical therapy to improve muscle strength and flexibility
- Provide occupational therapy to help manage daily activities
- Provide psychological therapy to help manage stress and anxiety
- Monitor for side effects of medications
- Monitor for signs of disease progression
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other giant cell arteritis - Prevention
Giant cell arteritis can be prevented by avoiding risk factors such as smoking, eating a healthy diet, exercising regularly, managing stress, and getting regular check-ups. additionally, it is important to be aware of any changes in the body that could indicate the onset of the disease, such as headaches, jaw pain, and vision changes.